Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-16T05:20:31.141Z Has data issue: false hasContentIssue false
  • English
  • Français

Tabaquismo en la esquizofrenia a largo plazo

Published online by Cambridge University Press:  12 May 2020

R. K. R. Salokangas ,
T. Honkonen ,
E. Stengård ,
A.-M. Koivisto  and
J. Hietala
R. K. R. Salokangas
Affiliation:
Departamento de Psiquiatría, Universidad de Turku, Clínica Psiquiátrica, Hospital Central Universitario de Turku, Clínica Psiquiátrica de Turku, 20520Turku, Finlandia
T. Honkonen
Affiliation:
Sección de Neurociencias Clínicas, Instituto Finlandés de Salud Ocupacional, Topeliuksenkatu 41aA, 00250Helsinki, Finlandia
E. Stengård
Affiliation:
Departamento de Psicología, Universidad de Tampere, 33014, Tampere, Finlandia
A.-M. Koivisto
Affiliation:
Escuela de Salud Pública de Tampere, Universidad de Tampere, 33101Tampere, Finlandia
J. Hietala
Affiliation:
Imágenes Neuropsiquiátricas, Centro de PET de Turku, Hospital Central Universitario de Turku, Clínica Psiquiátrica de Turku, 20520Turku, Finlandia
Get access

Resumen

Propósito.

El tabaquismo es un gran problema de salud prevalente entre los sujetos con esquizofrenia. Nuestro propósito era investigar la prevalencia y las asociaciones del tabaquismo en los pacientes con esquizofrenia a largo plazo.

Métodos.

Se entrevistó a 760 pacientes de esquizofrenia y se registró su consumo de cigarrillos.

Resultados.

El tabaquismo era más prevalente en los pacientes masculinos que en los femeninos. En el análisis de regresión logística, el género masculino, la duración de la enfermedad (DDE) de 10-19 años, estar divorciado o separado, un nivel educativo más bajo y las dosis diarias de neurolépticos (DDN) altas se asociaban significativamente con el hábito regular de fumar. Fumar mucho se asociaba, en hombres, con el tratamiento hospitalario.

Conclusiones.

En los pacientes de esquizofrenia, fumar se asocia con una DDE larga, con una DDN alta y la atención institucional. Las intervenciones para interrumpir o reducir el tabaquismo deben ser parte del tratamiento para los pacientes con esquizofrenia.

Keywords

TabaquismoAtención hospitalariaMedicación neurolépticaEsquizofreniaGénero
Type
Original
Information
European Psychiatry (Ed. Española) , Volume 13 , Issue 8 , November 2006 , pp. 375 - 379
Copyright
Copyright © European Psychiatric Association 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

Brown, SBirtwistle, JRoe, LThompson, C. The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999;29:697–701.CrossRefGoogle ScholarPubMed
Brown, SInskip, HBarraclough, B. Causes of the excess mortality of schizophrenia. Brit J Psychiat 2000;177:212–7.CrossRefGoogle ScholarPubMed
Clarke, PBS. Tobacco smoking, genes, and dopamine. Lancet 1998; 352:84–6.CrossRefGoogle ScholarPubMed
Court, JALloyd, SThomas, NPiggott, MAMarshall, EFMorris, CM, et al. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience 1998;87:63–78.CrossRefGoogle ScholarPubMed
Dalack, GWBecks, LHill, EPomerleau, OFMeador-Woodruff, JH. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacology 1999;21:195–202.CrossRefGoogle ScholarPubMed
De Leon, JDadvand, MCanuso, CWhite, AOStanilla, JKSimpson, GMSchizophrenia and smoking: an epidemiological survey in a State hospital. Am J Psychiatry 1995;152:453–5.Google ScholarPubMed
Pecina, PCaracci, GSandik, RBerman, WMukherjee, SScapicchio, P. and Cigarette smoking and neuroleptic-induced parkinsonism. Biol Psychiatry 1990;28:502–8.Google Scholar
Diwan, ACastine, MPomerleau, C-SMeador-Woodruff, JHDalack, GW. Differential prevalence of cigarette smoking in patients with schizophrenic vs. mood disorders. Schizophr Res 1998;33:113–8.CrossRefGoogle ScholarPubMed
Doll, RPeto, RWheatley, KGray, R. Mortality in relation to smoking: 40 years’ observation on British doctors. BMJ 1994;309:901–11.CrossRefGoogle Scholar
Endicott, JSpitzer, RLFieis, JLCohen, J. The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976;33:766–71.CrossRefGoogle ScholarPubMed
George, TPZiedonis, DMFeingold, APepper, WTSatterburg, CAWinkel, J, et al. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry 2000;157:1835–42.CrossRefGoogle Scholar
Glassman, AH. Cigarette smoking: implications for psychiatric illness. Am J Psychiatry 1993;150:546–53.Google ScholarPubMed
Goff, DCHenderson, DCArnica, BS. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am J Psychiatry 1992;149:1189–94.Google ScholarPubMed
Helakorpi, SUutela, APrättälä, RBerg, A-MPuska, P. Suomalaisen aikuisväeston terveyskäyttäytyminen, kevät 1997 (Health behaviour of Finnish adult population; in Finnish). Helsinki: Kansanterveyslaitoksen julkaisuja B10; 1997.Google Scholar
Herran, Ade-Santiago, ASandoya, MFernandez, MJDiez-Mannque, JFVazquez-Barquero, JLDeterminants of smoking behaviour in outpatients with schizophrenia. Schizophr Res 2000;41:373–81.CrossRefGoogle ScholarPubMed
Honkonen, TSaarinen, SSalokangas, RKR. Deinstitutionalization and schizophrenia in Finland II: discharged patients and their psychosocial functioning. Schizophr Bull 1999;25:547–55.CrossRefGoogle ScholarPubMed
Hughes, JRHatsukami, DKMitchell, JEDahlgren, LA. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 1986; 143:993–7.Google ScholarPubMed
Itkin, ONemets, BEinat, H. Smoking habits in bipolar and schizophrenic outpatients in Southern Israel. J Clin Psychiatry 2001; 62:269–72.CrossRefGoogle ScholarPubMed
Iversen, LL. Smoking harmful to the brain. Nature 1996;382:206–7.CrossRefGoogle ScholarPubMed
Jann, MSaklad, SREreshefsky, LRichards, ALHarington, CADavis, CM. Effects of smoking on haloperidol and reduced haloperidol plasma concentrations and haloperidol clearance. Psychopharmacol 1986;90:468–70.CrossRefGoogle ScholarPubMed
Jarvik, MESchneider, NG. Nicotine. In: Lowinson, JHRuiz, PMillman, RB editors. Substance Abuse: a comprehensive textbook, 2nd ed. Baltimore: Williams & Wilkins; 1992.Google Scholar
Laaksonen, MUutela, AVartiainen, EPekka, JousilahtiHelakorpi, SPuska, PDevelopment of smoking by birth cohort in the adult population in eastem Finland 1972-1997. Tob Control 1999;8:161–8.CrossRefGoogle Scholar
Levin, EDSimon, BB. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl) 1998; 138: 217–30.CrossRefGoogle ScholarPubMed
Lohr, JBFlynn, K. Smoking and schizophrenia. Schizophr Res 1992;8:93–102.CrossRefGoogle Scholar
Miller, RR. Effects of smoking on drug action. Clin Pharmacol Ther 1977;22:749–56.CrossRefGoogle ScholarPubMed
Peto, RLopez, ADBoreham, JThun, MHeath, C Jr.Doli, R. Mortality from smoking worldwide. Br Med Bull 1996;52:12–21.CrossRefGoogle ScholarPubMed
Salokangas, RKRHonkonen, TStengard, E. Discharged schizophrenia patients in the community—implications for Service development. A follow-up study of schizophrenia patients discharged from Finnish mental hospitals in 1982, 1986, 1990 and 1994. Psychiatria Fennica 2001;32(Suppl. 2):111–22.Google Scholar
Salokangas, RKRSaarijärvi, STaiminen, TLehto, HNiemi, HAhola, V, et al. Effect of smoking on neuroleptics in schizophrenia. Schizophr Res 1997;23:55–60.CrossRefGoogle Scholar
Salokangas, RKRSaarinen, S. Deinstitutionalisation and schizophrenia in Finland: discharged patients and their care. A follow-up study of schizophrenic patients discharged from Finnish mental hospitals in 1982, 1986 and 1990. Schizophr Bull 1998;24:457 67.CrossRefGoogle Scholar
Salokangas, RKRStengård, EHonkonen, TKoivisto, A-MSaarinen, S. Sairaalasta yhteiskuntaan. (From Hospital to the Community; Finnish report). Helsinki: STAKES, Raportteja 248; 2000.Google Scholar
Salokangas, RKRVilkman, HIlonen, TTaiminen, TBergman, JHaaparanta, M, et al. High levels of dopamine activity in the basal ganglio of cigarette smokers. Am J Psychiatry 2000;157:632–4.CrossRefGoogle Scholar
Strand, J-ENybäck, H. Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and Controls. Eur Psychiatry 2005;20:50–4.CrossRefGoogle ScholarPubMed
Ziedonis, DMKosten, TRGlazer, WMFrances, RJ. Nicotine dependence and schizophrenia. Hosp Com Psychiatry 1994;45:204–6.Google Scholar